Drug Solubility Enhancement Strategies Using Amorphous Solid Dispersion: Examination on Type and The Amount of the Polymer

Muhammad Seftian; Marlyn Dian Laksitorini; Teuku Nanda Saifullah Sulaiman

doi:10.24198/ijpst.v11i2.46908

Drug Solubility Enhancement Strategies Using Amorphous Solid Dispersion: Examination on Type and The Amount of the Polymer

Muhammad Seftian, Marlyn Dian Laksitorini, Teuku Nanda Saifullah Sulaiman

Abstrak

Solubility is one of the critical factors affecting the biopharmaceutical process of drugs. Low solubility limits the dissolution rate and the oral bioavailability. As a result, a higher drug load is required to compensate for the low bioavailability. Amorphous solid dispersion (ASD) is a recent approach to increase drug solubility by dispersing the drug in a carrier-commonly a hydrophilic polymer. It improves the solubility and dissolution rate by affecting the thermodynamic equilibrium of the drug in solution. The amorphous system has a random molecular arrangement leading to higher thermodynamic activity. The amorphous system in ASD has a higher free energy which facilitates a higher solubility and dissolution rate. Polymer is the main component after the active substance in the ASD system. Therefore, the success of ASD formulation will be determined by the selection of polymers and additives as well as their proportions in the system. In addition to the polymer, surfactants are used as a ternary system to give a synergistic effect on the dissolution rate. The system maintains drug supersaturation in the solution state through two main mechanisms: reducing molecular mobility and plasticizing effect.

Kata Kunci

amorphous solid dispersion; surfactants; polymers; dissolution

Teks Lengkap:

PDF (English)

Referensi

Amidon GL, Lennernas H, Shah VP, Crison JR. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharm Res. 1995;12(3):413–20.

Childs SL, Kandi P, Lingireddy SR. Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability. Mol Pharm. 2013;10(8):3112–27.

Medarević D, Cvijić S, Dobričić V, Mitrić M, Djuriš J, Ibrić S. Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach. Eur J Pharm Sci. 2018;124:188–98.

Ibrahim AH, Rosqvist E, Smått JH, Ibrahim HM, Ismael HR, Afouna MI, et al. Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin. Int J Pharm. 2019;563:217–27.

Li Y, Li C, Gao X, Lv H. Nitazoxanide in aqueous co-solvent solutions of isopropanol/DMF/NMP: Solubility, solvation thermodynamics and intermolecular interactions. J Chem Thermodyn. 2023;176.

Gao L, Zhang XR. Pharmaceutical salt hydrates of vortioxetine with maleic acid and fumaric acid: Crystal structures, characterisation and solubility performance. J Mol Struct. 2022;1250:1–10.

Sun X, Zhu J, Liu C, Wang D, Wang CY. Fabrication of fucoxanthin/2-hydroxypropyl-β-cyclodextrin inclusion complex assisted by ultrasound procedure to enhance aqueous solubility, stability and antitumor effect of fucoxanthin. Ultrason Sonochem. 2022;90.

Guan J, Jin L, Liu Q, Xu H, Wu H, Zhang X, et al. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption. Eur J Pharm Sci. 2019;139.

Choi JS, Park JS. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. Eur J Pharm Sci. 2017;97:269–76.

Chella N, Daravath B, Kumar D, Tadikonda RR. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan. Eur J Drug Metab Pharmacokinet. 2016;41(5):517–26.

Bhujbal S V., Mitra B, Jain U, Gong Y, Agrawal A, Karki S, et al. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm Sin B. 2021;11(8):2505–36.

Vullendula SKA, Nair AR, Yarlagadda DL, Navya Sree KS, Bhat K, Dengale SJ. Polymeric solid dispersion Vs co-amorphous technology: A critical comparison. J Drug Deliv Sci Technol. 2022;78.

Halász AS. Solubility as a Challenge in Drug Research and Development. In: Tihanyi K, Vastag M, editors. Solubility, Delivery and ADME Problems of Drugs and Drug_Candidates. Budapest: Bentham e-Books; 2011. p. 52–67.

Indulkar AS, Lou X, Zhang GGZ, Taylor LS. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance. Mol Pharm. 2019;16(3):1327–39.

Surwase SA, Itkonen L, Aaltonen J, Saville D, Rades T, Peltonen L, et al. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension. Eur J Pharm Biopharm. 2015;96:32–43.

Jørgensen JR, Mohr W, Rischer M, Sauer A, Mistry S, Müllertz A, et al. Stability and intrinsic dissolution of vacuum compression molded amorphous solid dispersions of efavirenz. Int J Pharm. 2023;632.

Xu H, Zhao T, Liu F, Zhang Y, Xie Y, Xiao X, et al. Dihydromyricetin solid dispersion: Preparation, characterization, and preservative effects on sturgeon fillets stored at 4 °C. Lwt. 2023;174.

Nupur MA, Rahman MM, Akter K, Hanif KB, Sharna JF, Sarker MS, et al. Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice. Heliyon. 2023;9(5).

Sharma P, Ruchika, Dhiman P, Kumar R, Saneja A, Singh D. A solid dispersion of Citrus reticulata peel biowaste as an effective antiepileptic: Sustainable approach toward value addition and agro-industrial waste valorisation. J Drug Deliv Sci Technol. 2023;81.

Yu C, Zhang C, Guan X, Yuan D. Journal of Drug Delivery Science and Technology The solid dispersion of resveratrol with enhanced dissolution and good system physical stability. 2023;84.

Krstić M, Manić L, Martić N, Vasiljević D, Mračević SĐ, Vukmirović S, et al. Binary polymeric amorphous carvedilol solid dispersions: In vitro and in vivo characterization. Eur J Pharm Sci. 2020;150.

Dengale SJ, Grohganz H, Rades T, Löbmann K. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev. 2016;100:116–25.

Yarlagadda DL, Sai Krishna Anand V, Nair AR, Navya Sree KS, Dengale SJ, Bhat K. Considerations for the selection of co-formers in the preparation of co-amorphous formulations. Int J Pharm. 2021;602.

Vasconcelos T, Prezotti F, Araújo F, Lopes C, Loureiro A, Marques S, et al. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol. Int J Pharm. 2021;595.

Pinto JMO, Leão AF, Riekes MK, França MT, Stulzer HK. HPMCAS as an effective precipitation inhibitor in amorphous solid dispersions of the poorly soluble drug candesartan cilexetil. Carbohydr Polym. 2018;184:199–206.

Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50(1):47–60.

Shetty D, Yarlagadda DL, Brahmam B, Swapnil J, Lewis SA. Investigating the influence of the type of polymer on sustaining the supersaturation from amorphous solid dispersions of Apremilast and its pharmacokinetics. ournal Drug Deliv Sci Technol. 2023;

Tian Y, Jones DS, Andrews GP. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Mol Pharm. 2015;12(4):1180–92.

Davis MT, Potter CB, Mohammadpour M, Albadarin AB, Walker GM. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions. Int J Pharm. 2017;519(1–2):365–72.

Wu W, Ueda H, Löbmann K, Rades T, Grohganz H. Organic acids as co-formers for co-amorphous systems – Influence of variation in molar ratio on the physicochemical properties of the co-amorphous systems. Eur J Pharm Biopharm. 2018;131:25–32.

Kallakunta VR, Sarabu S, Bandari S, Batra A, Bi V, Durig T, et al. Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: Effect of formulation and process parameters for a low glass transition temperature drug. J Drug Deliv Sci Technol. 2020;58.

Kaur N, Narang A, Bansal AK, Narang A, Bansal AK. Use of Biorelevant Dissolution and PBPK Modeling to Predict Oral Drug Absorption. Eur J Pharm Biopharm. 2018;

Taylor LS, Zhang GGZ. Physical chemistry of supersaturated solutions and implications for 2 oral absorption. Adv Drug Deliv Rev. 2016;

Que C, Lou X, Zemlyanov DY, Mo H, Indulkar AS, Gao Y, et al. Insights into the Dissolution Behavior of Ledipasvir-Copovidone Amorphous Solid Dispersions: Role of Drug Loading and Intermolecular Interactions. Mol Pharm. 2019;16(12):5054–67.

Yen C-W, Kuhn R, Hu C, Zhang W, Chiang P-C, Chen JZ, et al. Impact of surfactant selection and incorporation on in situ nanoparticle formation from amorphous solid dispersions. Int J Pharm. 2021;607.

Correa-Soto CE, Gao Y, Indulkar AS, Zhang GGZ, Taylor LS. Role of surfactants in improving release from higher drug loading amorphous solid dispersions. Int J Pharm. 2022;625(May).

Lu Y, Chen J, Yi S, Xiong S. Enhanced felodipine dissolution from high drug loading amorphous solid dispersions with PVP/VA and sodium dodecyl sulfate. J Drug Deliv Sci Technol. 2019;53(April).

Saha SK, Joshi A, Singh R, Jana S, Dubey K, Joshi A, et al. An investigation into solubility and dissolution improvement of Alectinib Hydrochloride as a third-generation amorphous solid dispersion. J Drug Deliv Sci Technol. 2023;1–8.

Qian S, Li Z, Heng W, Liang S, Ma D, Gao Y, et al. Charge-assisted intermolecular hydrogen bond formed in coamorphous system is important to relieve the pH-dependent solubility behavior of lurasidone hydrochloride. RSC Adv. 2016;6(108):106396–412.

Song CK, Yoon I-S, Kim D-D. Poloxamer-based solid dispersions for oral delivery of docetaxel: Differential effects of F68 and P85 on oral docetaxel bioavailability. Int J Pharm [Internet]. 2016;507:102–8. Available from: https://www.ptonline.com/articles/how-to-get-better-mfi-results

Xi Z, Fei Y, Wang Y, Lin Q, Ke Q, Feng G, et al. Solubility improvement of curcumin by crystallization inhibition from polymeric surfactants in amorphous solid dispersions. Sci Total Environ. 2023. Available from: https://doi.org/10.1016/j.scitotenv.2020.143747

Torrado-Salmerón C, Guarnizo-Herrero V, Torrado G, Peña MÁ, Torrado-Santiago S, de la Torre-Iglesias PM. Solid dispersions of atorvastatin with Kolliphor RH40: Enhanced supersaturation and improvement in a hyperlipidemic rat model. Int J Pharm. 2023;631.

DOI: https://doi.org/10.24198/ijpst.v11i2.46908